Dihydropyridine calcium channel blockers inhibit non-esterified-fatty-acid-induced endothelial and rheological dysfunction

Clinical Science

Volumn 125, Issue 5, 2013, Pages 247-255

  Yasu, Takanori ^a,c   kobayashi, Mayumi ^a   Mutoh, Akiko ^a   Yamakawa, Ken ^a   Momomura, Shin ichi ^b   Ueda, Shinichiro ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Calcium channel blocker; Endothelial function; Leucocyte; Non esterified fatty acid (NEFA); Oxidative stress

Indexed keywords

ACETYLCHOLINE; AMLODIPINE; DILTIAZEM; FATTY ACID; HEPARIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MYELOPEROXIDASE; NIFEDIPINE; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD RHEOLOGY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENDOTHELIAL DYSFUNCTION; ENZYME BLOOD LEVEL; EX VIVO STUDY; FATTY ACID BLOOD LEVEL; FOREARM BLOOD FLOW; HUMAN; HUMAN CELL; INFUSION; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MALE; MEASUREMENT; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TREATMENT DURATION;

ADULT; ANTIOXIDANTS; CALCIUM CHANNEL BLOCKERS; CELL LINE; CROSS-OVER STUDIES; DIHYDROPYRIDINES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FATTY ACIDS, NONESTERIFIED; HEMORHEOLOGY; HUMANS; LEUKOCYTES; MALE; OXIDATIVE STRESS; PHOSPHORYLATION; TRANSCRIPTION FACTOR RELA; YOUNG ADULT;

EID: 84878538866     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120311     Document Type: Article

References (50)

1. Laws, A., Hoen, H. M., Selby, J. V., Saad, M. F., Haffner, S. M. and Howard, B. V. (1997) Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler. Thromb. Vasc. Biol. 17, 64-71
2. Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G. and Baron, A. D. (1996) Obesity/insulin resistance is associated with endothelial dysfunction: implications for syndrome of insulin resistance. J. Clin. Invest. 97, 2601-2626
3. Steinberg, H. O., Tarshoby, M., Monestel, R., Hook, G., Cronin, J., Johnson, A., Bayazeed, B. and Baron, A. D. (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J. Clin. Invest. 100, 1230-1239
4. Carlsson, M., Wessman, Y., Almgren, P. and Groop, L. (2000) High levels of nonesterfied fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 20, 1588-1594
5. Pilz, S., Scharnagl, H., Tiran, B., Seelhorst, U., Wellnitz, B., Bernhard, O., Jürgen, R. S. and Marz, W. S. (2006) Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J. Clin. Endocrinol. Metab. 90, 3622-3628
6. Pleiner, J., Schaller, G., Mittermayer, F., Bayerle-Eder, M., Roden, M. and Wolzt, M. (2002) FFA-induced endothelial dysfunction can be corrected by vitamin C. J. Clin. Endocrinol. Metab. 87, 2913-2917
7. Watanabe, S., Tagawa, T., Yamakawa, K., Shimabukuro, M. and Ueda, S. (2005) Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans. Arterioscler. Thromb. Vasc. Biol. 25, 2376-2380
8. Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M. et al. (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49, 1939-1945
9. Yu, H. Y., Inoguchi, T., Kakimoto, M., Nakashima, N., Imamura, M., Hashimoto, T., Umeda, F. and Nawata, H. (2001) Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase C activity in cultured aortic smooth muscle cells. Diabetologia 44, 614-620
10. Azekosi, Y., Yasu, T., Watanabe, S., Tagawa, T., Abe, S., Yamakawa, K., Uehara, Y., Momomura, S., Urata, H. and Ueda, S. (2010) FFA causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells. Hypertension 56, 136-142
11. Eiserich, J. P., Baldus, S., Brennan, M. L., Ma, W., Zhang, C., Tousson, A., Castro, L., Lusis, A. J., William, M., Nauseef, W. M. et al. (2002) Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296, 2391-2394
12. Berkels, R., Egink, G., Marsen, T. A., Bartels, H., Roesen, R. and Klaus, W. (2001) Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. Hypertension 37, 240-245
13. Brovkovych, V., Kalinowski, L., Muller-Peddinghaus, R. and Malinski, T. (2001) Synergistic antihypertensive effects of nifedipine on endothelium: concurrent release of NO and scavenging of superoxide. Hypertension 37, 34-39
14. Fukuo, K., Yang, J., Yasuda, O., Mogi, M., Suhara, T., Sato, N., Suzuki, T., Morimoto, S. and Ogihara, T. (2002) Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways. Circulation 16, 356-361
15. Toma, L., Stancu, C. S., Sanda, G. M. and Sima, A. V. (2011) Antioxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL. Biochem. Biophys. Res. Commun. 411, 202-207
16. Okuda, N., Hayashi, T., Mori, T., Inamoto, S., Okabe, M., Mieno, S., Horimoto, H. and Kitaura, Y. (2005) Nifedipine enhances the cardioprotective effect of an angiotensin II receptor blocker in an experimental animal model of heart failure. Hypertens. Res. 28, 431-438
17. + release from intracellular stores in neutrophils. J. Biol. Chem. 267, 1443-1448
18. Levy, R., Nagauker-Shriker, O. and Schlaeffer, F. (1996) Inhibited neutrophil functions in patients treated with nifedipine but not with verapamil or diltiazem. Eur. J. Clin. Invest. 26, 376-381 19 Feng, Y. H. and Hart, G. (1996) Suppression of oxidant production by diltiazem, nifedipine and verapamil in human neutrophils. Clin. Sci. 91, 459-466
19. Feng, Y. H. and Hart, G. (1996) Suppression of oxidant production by diltiazem, nifedipine and verapamil in human neutrophils. Clin. Sci. 91, 459-466
20. Irita, K., Fujita, I., Takeshige, K. and Minakami, S. (1986) Calcium channel antagonist induced inhibition of superoxide production in human neutrophils. Mechanisms independent of antagonizing calcium influx. Biochem. Pharmacol. 35, 3465-3471
21. ENCORE Investigators (2003) Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin on Recovery of Coronary Endothelial Function). Circulation 107, 422-428
22. Verhaar, M. C., Honing, M. L., van Dam, T., Zwart, M., Koomans, H. A., Kastelein, J. J. and Rabelink, T. J. (1999) Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids. Cardiovasc. Res. 42, 752-760
23. Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A., Favilla, S., Pompella, A. and Salvetti, A. (2001) Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 37, 943-948
24. Muiesan, M. L., Salvetti, M., Monteduro, C., Rizzoni, D., Zulli, R., Corbellini, C., Brun, C. and Agabiti-Rosei, E. (1999) Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension. Hypertension 3, 575-580
25. Poole-Wilson, P. A., Lubsen, J., Kirwan, B. A., van Dalen, F. J., Wagener, G., Danchin, N., Just, H., Fox, K. A., Pocock, S. J., Clayton, T. C. et al. (2004) Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 364, 849-857
26. Nissen, S. E., Tuzcu, E. M., Libby, P., Thompson, P. D., Ghali, M., Garza, D., Berman, L., Shi, H., Buebendorf, E. and Topol, E. J. (2004) Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 292, 2217-2225
27. Ueda, S., Wada, A. and Umemura, S. (2004) Methodological validity and feasibility of NO clamp research in human resistance vessels. Hypertens. Res. 27, 351-357
28. Zambon, A., Hashimoto, S. I. and Brunzell, J. D. (1993) Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J. Lipid Res. 34, 1021-1028
29. Cornelli, U., Terranova, R., Luca, S., Cornelli, M. and Alberti, A. (2001) Bioavailability and antioxidant activity of some food supplements in men and women using the d-ROMs test as a marker of oxidative stress. J. Nutr. 131, 3208-3211
30. Vassalle, C., Boni, C., Cecco, P. D. and Landi, P. (2006) Elevated hydroperoxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease. Int. J. Cardiol. 110, 415-416
31. Ridker, P. M., Brown, N. J., Vaughan, D. E., Harrison, D. G. and Mehta, J. L. (2004) Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109 (Suppl. IV), IV-6-IV-19
32. Fukuda, S., Yasu, T., Kobayashi, N., Ikeda, N. and Schmid-Shönbein, G. W. (2004) Contribution of fluid shear response in leukocytes to hemodynamic resistance in the spontaneously hypertensive rat. Circ. Res. 95, 100-108
33. Ikeda, N., Yasu, T., Tsuboi, K., Sugawara, Y., Kubo, N., Umemoto, T., Arao, K., Kawakami, M. and Momomura, S. (2010) Effects of submaximal exercise on blood rheology and sympathetic nerve activity. Circ. J. 74, 730-734
34. Arao, K., Yasu, T., Umemoto, T., Jinbo, S., Ikeda, N., Ueda, S., Kawakami, M. and Momomura, S. (2009) Effects of pitavastatin on postprandial endothelial function, oxidative stress, and hemorheology in patients with stable angina pectoris. Circ. J. 73, 1523-1530
35. Baldus, S., Rudolph, V., Roiss, M., Ito, W. D., Rudolph, T. K., Eiserich, J. P., Sydow, K., Lau, D., Szöcs, K., Klinke, A. et al. (2006) Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 113, 1871-1878
36. Nakamura, H., Nakamura, K. and Yodoi, J. (1997) Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351-369
37. Fukuda, S., Yasu, T., Predescu, D. N. and Schmid-Schönbein, G. W. (2000) Mechanisms for regulation of fluid shear stress response in circulating leukocytes. Circ. Res. 86, E13-18
38. Yasu, T., Ikeda, N., Ishizuka, N., Matsuda, E., Kawakami, M., Kuroki, M., Nobuo, I., Ueba, H., Fukuda, S., Schmid-Schönbein, G. W. and Saito, M. (2002) Nicorandil and leukocyte activation. J. Cardiovasc. Pharmacol. 40, 684-692
39. Sugiura, T., Kondo, T., Kureishi-Bando, Y, Numaguchi, Y., Yoshida, O., Dohi, Y., Kimura, G., Ueda, R., Rabelink, T. J. and Murohara, T. (2008) Nifedipine improves endothelialfunction: role of endothelial progenitor cells. Hypertension 52, 491-498
40. Miura, S., Fujino, M., Matsuo, Y., Tanigawa, H. and Saku, K. (2005) Nifedipine-induced vascular endothelial growth factor secretion from coronary smooth muscle cells promotes endothelial tube formation via the kinase insert domain-containing receptor/fetal liver kinase-1/NO pathway. Hypertens. Res. 28, 147-153
41. Batova, S., DeWever, J., Godfraind, T., Balligand, J. L., Dessy, C. and Feron, O. (2006) The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. Cardiovasc. Res. 71, 478-485
42. Grafton, G. L., Stokes, L, Toellner, K. M. and Gordon, J. (2003) A non-voltage-gated calcium channel with L-type characteristics activated by B cell receptor ligation. Biochem. Pharmacol. 66, 2001-2009
43. Akha, A. A. S., Willmott, N. J., Brickley, K., Dolphin, A. C., Galione, A. and Hunt, S. V. (1996) Anti-Ig-induced calcium influx in rat B lymphocytes mediated by cGMP through a dhydropyridine-sensitive channel. J. Biol. Chem. 271, 7297-7700
44. Kotturi, M. F., Carlow, D. A., Lee, J. C., Ziltener, H. J. and Jefferies, W. A. (2003) Identification and functional characterization of voltage-dependent calcium channels in T lymphocytes. J. Biol. Chem. 278, 46949-46960
45. Krol, E., Agueel, R., Banue, S., Smogorzewski, M., Kumar, D. and Massry, S. G. (2003) Amlodipine reverses the elevation in [Ca2+ ]i and the impairment of phagocytosis in PMNLs of NIDDM patients. Kidney Int. 64, 2188-2195
46. + on rapid and transient contents of superoxide generation in differentiated THP-1 cells. Biochem. Biophys. Res. Commun. 344, 571-580
47. Shima, E., Katsube, M., Kato, T., Kitagawa, M., Hato, F., Hino, M., Takahashi, T., Fujita, H. and Kitagawa, S. (2008) Calcium channel blockers suppress cytokine-induced activation of human neutrophils. Am. J. Hypertens. 21, 78-84
48. Savignac, M., Badou, A., Moreau, M., Leclerc, C., Gu'ery, J. C., Paulet, P., Druet, P., Ragab-Thomas, J. and Pelletier, L. (2001) Protein kinase C-mediated calcium entry dependent upon dihydropyridine sensitive channels: a T cell receptor-coupled signaling pathway involved in IL-4 synthesis. FASEB J. 15, 1577-1579
49. El Bekay, R., Alvarez, M., Monteseir'in, J., Alba, G., Chac'on, P., Vega, A., Martin-Nieto, J., Jim'enez, J., Pintado, E., Bedoya, F. J. and Sobrino, F. (2003) Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-B. Blood 102, 662-671
50. Matsumori, A., Nunokawa, Y. and Sasayama, S. (2000) Nifedipine inhibits activation of transcription factor NF-B. Life Sci. 67, 2655-2661